CUTISS receives new patent for skin engineering technology

CUTISS has been granted a new U.S. patent. It covers automated methods and systems for producing skin grafts, including the separation of skin layers and the isolation of key cell types from a skin biopsy.

The patented invention relates to a broader automated workflow for skin graft production, in which a skin biopsy may be separated into dermis and epidermis, fibroblasts and keratinocytes isolated and expanded, and a skin graft formed under automated control. According to the patent, this approach is intended to support a more controlled and efficient manufacturing process.

This new patent further strengthens our intellectual property portfolio and supports the broader strategy to advance standardized and scalable manufacturing for personalized skin tissue therapy.

U.S. Patent No. 12,599,401 B2 – titled “Methods and systems for producing skin grafts” – granted on 14 April 2026 and assigned to CUTISS AG.